Skip to main content

GRObio’s groundbreaking science
redefines protein therapeutics with
an expanded amino acid alphabet

We have developed the only synthetic biology platform that grants access to the full universe of non-standard amino acids (NSAAs) with novel therapeutic applications.

More About Us

Watch the Company Overview

The GRO Platform

The GRO platform removes the barriers historically associated with protein therapeutics.

By granting access to the full universe of non-standard amino acids (NSAAs), the GRO platform overcomes the limitations on potency, immunogenicity, and stability impairing therapeutics constructed from the 20 standard amino acids.

Solid GRO Bioscience Blue Circle
Gradient Circle
Science Woman
Gradient Circle Overlay

ProGly™ Programs

Our programs are focused in two primary areas: reversing autoimmunity and eliminating immunogenicity.

ProGly™ NSAAs are pre-glycosylated amino acids installed by the GRO platform that provide precise control over the glycan composition on any protein. We use this approach to reeducate the immune system to reverse autoimmune processes.

Light Blue Solid Circle
Gradient Background Circle
Elderly Man with grandson
Gradient Circle Overlay

Featured News

April 3, 2024 in Featured News, News

STAT: Up and down the ladder: The latest comings and goings

As seen in an Up and Down the Ladder STAT column, Ed Silverman interviewed Tracey Lodie, our newly appointed Chief Development Officer, to explore her interest beyond her role at…
Read More
March 18, 2024 in Featured News, Press Releases

GRO Biosciences Expands Executive Team with Appointment of Biopharma Veteran Tracey Lodie, PhD as Chief Development Officer

BOSTON, March 18, 2024 - GRO Biosciences Inc. (“GRObio”), an emerging biotechnology company leveraging synthetic biology to expand the amino acid alphabet and deliver on the promise of protein therapeutics,…
Read More
October 10, 2023 in Featured News, News

Biorasi’s Few & Far Between Podcast: Breakthroughs in Protein Design – from Biocontainment to Creating a New Amino Acid Alphabet

In this episode, Biorasi CEO Chris O’Brien hosted scientist and entrepreneur Daniel J. Mandell, Ph.D. to discuss how his creativity and imagination led him on a journey to developing the…
Read More